Table 2.
Distribution of cases based on estrogen receptor and progesterone receptor status in tumor mass
| ER-PR status | Number of patients (%) |
|---|---|
| ER+ and PR+ | 23 (38.33) |
| ER+ and PR− | 1 (1.67) |
| ER− and PR− | 36 (60) |
| Total | 60 (100) |
ER: Estrogen receptor; PR: Progesterone receptor